ATE554754T1 - Verfahren zur herstellung und verwendung von eisenhaltigen pyrophosphat-citrat-chelat- zusammensetzungen - Google Patents

Verfahren zur herstellung und verwendung von eisenhaltigen pyrophosphat-citrat-chelat- zusammensetzungen

Info

Publication number
ATE554754T1
ATE554754T1 AT08159949T AT08159949T ATE554754T1 AT E554754 T1 ATE554754 T1 AT E554754T1 AT 08159949 T AT08159949 T AT 08159949T AT 08159949 T AT08159949 T AT 08159949T AT E554754 T1 ATE554754 T1 AT E554754T1
Authority
AT
Austria
Prior art keywords
ferric
citrate
iron
production
chelate
Prior art date
Application number
AT08159949T
Other languages
English (en)
Inventor
William S Mccall Jr
Original Assignee
Rockwell Medical Technologies Inc A Corp Of The State Of Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockwell Medical Technologies Inc A Corp Of The State Of Michigan filed Critical Rockwell Medical Technologies Inc A Corp Of The State Of Michigan
Application granted granted Critical
Publication of ATE554754T1 publication Critical patent/ATE554754T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dental Preparations (AREA)
AT08159949T 2007-07-20 2008-07-08 Verfahren zur herstellung und verwendung von eisenhaltigen pyrophosphat-citrat-chelat- zusammensetzungen ATE554754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96132707P 2007-07-20 2007-07-20
US12/138,018 US7816404B2 (en) 2007-07-20 2008-06-12 Methods for the preparation and use of ferric pyrophosphate citrate chelate compositions

Publications (1)

Publication Number Publication Date
ATE554754T1 true ATE554754T1 (de) 2012-05-15

Family

ID=40019183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08159949T ATE554754T1 (de) 2007-07-20 2008-07-08 Verfahren zur herstellung und verwendung von eisenhaltigen pyrophosphat-citrat-chelat- zusammensetzungen

Country Status (11)

Country Link
US (1) US7816404B2 (de)
EP (1) EP2016940B1 (de)
JP (1) JP5489196B2 (de)
AT (1) ATE554754T1 (de)
CY (1) CY1113903T1 (de)
DK (1) DK2016940T3 (de)
ES (1) ES2383713T3 (de)
HR (1) HRP20120416T1 (de)
PL (1) PL2016940T3 (de)
PT (1) PT2016940E (de)
SI (1) SI2016940T1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090124572A1 (en) * 2007-11-09 2009-05-14 Deanna Jean Nelson Iron-containing nutritional supplement
AU2009262967C1 (en) 2008-06-25 2015-12-24 Fe3 Medical, Inc Patches and methods for the transdermal delivery of a therapeutically effective amount of iron
WO2010034359A1 (en) * 2008-09-29 2010-04-01 Vifor (International) Ag Receptacle and method for storing and supplying a liquid and a liquid medical preparation
US8348922B2 (en) * 2009-02-12 2013-01-08 Incube Labs, Llc Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent
US9008765B2 (en) 2009-02-12 2015-04-14 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
US8190252B2 (en) * 2009-02-12 2012-05-29 Incube Labs, Llc Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
US8961492B2 (en) 2009-02-12 2015-02-24 Incube Labs, Llc System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010151845A2 (en) * 2009-06-26 2010-12-29 Incube Labs, Llc Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use
US8178709B2 (en) * 2009-07-21 2012-05-15 Biolink Life Sciences, Inc. Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof
WO2011044175A2 (en) 2009-10-06 2011-04-14 Incube Labs, Llc Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
US8685038B2 (en) 2009-12-07 2014-04-01 Incube Labs, Llc Iontophoretic apparatus and method for marking of the skin
WO2011100376A2 (en) 2010-02-10 2011-08-18 Incube Labs, Llc Methods and architecture for power optimization of iontophoretic transdermal drug delivery
EP2497380A1 (de) * 2011-03-10 2012-09-12 DSM IP Assets B.V. Verfahren für die Eisenergänzung in Getränken
AU2012230701B2 (en) 2011-03-24 2016-09-29 Incube Labs, Llc System and method for biphasic transdermal iontophoretic delivery of therapeutic agents
RU2472500C1 (ru) * 2012-05-05 2013-01-20 Илья Николаевич Медведев Способ нормализации активности антитромбина iii в крови у новорожденных телят с железодефицитной анемией
US20150320091A1 (en) * 2012-05-08 2015-11-12 Dsm Ip Assets B.V. Iron supplementation of rice kernels
JP2016507527A (ja) 2013-02-01 2016-03-10 チャラク エルエルシー 可溶性ピロリン酸第二鉄を用いて鉄欠乏症を治療する方法
EP3038475B1 (de) * 2013-08-28 2018-06-27 DSM IP Assets B.V. Eisenergänzung eines bouillonkonzentrats
WO2015069656A1 (en) 2013-11-05 2015-05-14 Rockwell Medical, Inc. Methods of reducing doses of erythropoietin stimulating agents in hyporesponsive patients
EP3157516A4 (de) 2014-06-22 2017-12-13 Dexcel Pharma Technologies Ltd. Pharmazeutische zusammensetzungen mit eisencitrat und verfahren zur herstellung davon
JP5963185B1 (ja) * 2015-04-13 2016-08-03 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
EP3284717B1 (de) * 2015-04-13 2019-10-30 Tomita Pharmaceutical Co., Ltd. Pulver mit eisenpyrophosphat und verfahren zur herstellung davon
WO2017040937A1 (en) * 2015-09-04 2017-03-09 Rockwell Medical, Inc. Solid soluble ferric pyrophosphate formulations, kits, and methods using the same
EP3153162A1 (de) 2015-10-05 2017-04-12 Navinta, llc. Herstellung von pharmazeutischen darreichungsformen mit eisen-(iii)-salzen
CN108883085A (zh) 2016-01-06 2018-11-23 罗克韦尔医疗公司 用铁化合物和柠檬酸盐化合物的组合物疗法
CN106977552B (zh) * 2016-01-19 2019-11-05 山东诚创医药技术开发有限公司 枸橼酸焦磷酸铁混配络合物的制备方法
JP6887598B2 (ja) * 2016-07-21 2021-06-16 富田製薬株式会社 鉄含有飲食品
CN106619494A (zh) * 2016-10-10 2017-05-10 泰州海达医药科技有限公司 枸橼酸焦磷酸铁溶液及其制备方法
MX2019011725A (es) 2017-03-31 2020-07-28 Abbott Lab Composiciones nutricionales liquidas que contienen aceite de pescado oxidable, acido rosmarinico y hierro ferrico.
EP3778868B1 (de) 2019-08-16 2022-01-26 UGA Biopharma GmbH Zellkulturmedium zur kultivierung von zellen, verfahren zum kultivieren von zellen und verfahren zur expression von mindestens einem rekombinanten protein in einer zellkultur
CN112159434A (zh) * 2020-09-23 2021-01-01 北京沣瑞医药科技有限公司 枸橼酸焦磷酸铁配合物的制备方法
CA3191492A1 (en) * 2020-09-29 2022-04-07 LG Bionano, LLC Methods of preparing iron complexes
CN112516163A (zh) * 2020-12-21 2021-03-19 西安医学院 一种难溶性三价铁纳米脂质体复合物及其制备方法
WO2026017901A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in neurodevelopmental or psychiatric disorder

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE579299A (de) * 1958-06-04
US3275514A (en) * 1960-04-12 1966-09-27 Paul D Saltman Process for introduction of metals into the mammalian system
US3259500A (en) * 1961-10-11 1966-07-05 Kentucky Res Foundation Method for inhibiting anemia in young pigs by feeding the sow an iron agent
US3367834A (en) * 1965-05-04 1968-02-06 Dexter Martin Method and compositions for enhancing the utilization of iron by mammals
AT279048B (de) * 1967-07-04 1970-02-25 Pharmazeutische Fabrik Montavit Gmbh Verfahren zur Herstellung neuer, löslicher und stabiler organischer Eisen(III)-Komplexverbindungen und Injektionslösungen davon
US3686397A (en) * 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
SE359447B (de) * 1971-10-06 1973-09-03 Astra Laekemedel Ab
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
US4058621A (en) * 1975-02-24 1977-11-15 Peter, Strong & Company, Inc. Iron complexes and foodstuffs containing them
JPS5626709A (en) * 1979-08-04 1981-03-14 Nichia Kagaku Kogyo Kk Manufacture of water soluble iron salt
EP0107458B1 (de) * 1982-10-22 1987-07-29 National Research Development Corporation Pharmazeutische Zusammensetzungen
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8713169D0 (en) * 1987-06-05 1987-07-08 Peters T J Uptake of iron by body
CO4410161A1 (es) 1994-02-28 1997-01-09 Kellog Co Producto de cereal listo para comer fortificado con complejo de edta ferrico y metodo para producirlo
DE69734781T2 (de) * 1996-12-31 2006-07-20 Gupta, Ajay, Cerritos Verfahren und pharmazeutische zusammensetzung zum zuführen von eisen bei hämodialyse-und peritonealdialysepatienten
WO2001000204A1 (en) 1999-06-30 2001-01-04 Ajay Gupta Method and pharmaceutical composition for parenteral administration of iron
US20030190355A1 (en) 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
PT1973552T (pt) * 2005-12-23 2017-07-18 Gupta Ajay Composição para nutrição parenteral contendo ferro

Also Published As

Publication number Publication date
SI2016940T1 (sl) 2012-07-31
HRP20120416T1 (hr) 2012-07-31
ES2383713T3 (es) 2012-06-25
PL2016940T3 (pl) 2012-09-28
US7816404B2 (en) 2010-10-19
JP5489196B2 (ja) 2014-05-14
EP2016940B1 (de) 2012-04-25
JP2009108027A (ja) 2009-05-21
US20090023686A1 (en) 2009-01-22
DK2016940T3 (da) 2012-06-18
CY1113903T1 (el) 2016-07-27
PT2016940E (pt) 2012-07-12
EP2016940A1 (de) 2009-01-21

Similar Documents

Publication Publication Date Title
ATE554754T1 (de) Verfahren zur herstellung und verwendung von eisenhaltigen pyrophosphat-citrat-chelat- zusammensetzungen
NZ580226A (en) Dimer compounds as inhibitors of iap
BRPI0409198A (pt) derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
MX2010009654A (es) Derivados de acido carboxilico de conformacion restringida utiles para tratar trastornos metabolicos.
EA201001143A1 (ru) Активаторы прокаспаз "исполнителей" 3, 6 и 7
GEP20084551B (en) 4-phenylamino-quinazolin-6-yl-amides
TW200616541A (en) Benzoyl-substituted serineamides
MX2010007605A (es) Pirrolo-pirimidas y pirrolo-piridinas.
GB0305152D0 (en) Organic compounds
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
TW200716558A (en) Heteroaroyl-substituted serineamides
NZ597075A (en) 1, 2, 4-thiazolidin-3-one derivatives as AMP-activated protein kinase (AMPK) agonists for treating cancer
NZ607600A (en) Compositions for the treatment of diseases
MX343326B (es) Metodos para mejorar el metabolismo energetico.
EA201170116A1 (ru) Фосфат-связывающие материалы и их применение
MX2010005867A (es) Polimorfos de un inhibidor de c-met/hgfr.
MX2010002042A (es) Derivados de 1,3-dihidroisoindol.
EP2131849A4 (de) Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs
ATE547009T1 (de) Zusammensetzungen und verfahren zur förderung von körperfettverlust
TW200603746A (en) Iron sulfate based phosphate adsorbent
MX365193B (es) Uso de semilla de palta para obtener aceite de palta enriquecido en alquil polioles y/o sus derivados acetilados.
WO2008113013A3 (en) C-met mutations and uses thereof
MD20130009A2 (en) Fungicidal composition and method for treating plants
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
ZA202108762B (en) Surface-treated magnesium or calcium ion-containing materials as white pigments in oral care compositions